Clinical trial
Post-COVID 19 Patients Undergoing Surgery: Determination of Residual Lung Abnormalities and Postoperative Adverse Effects
NCT04922931 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-COVID 19 Patients Undergoing Surgery: Determination of Residual Lung Abnormalities and Postoperative Adverse Effects
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2020
- Completion date
- April 5, 2021
- Enrollment
- 207 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19